Adrenoceptors in GtoPdb v. 2021.3

K Altosaar, P Balaji, RA Bond, DB Bylund… - IUPHAR/BPS Guide …, 2021 - journals.ed.ac.uk
Adrenoceptors in GtoPdb v.2021.3 Page 1 IUPHAR/BPS Guide to Pharmacology CITE https://doi.org/10.2218/gtopdb/F4/2021.3
Adrenoceptors in GtoPdb v.2021.3 Katrin Altosaar1, Poornima Balaji2, Richard A. Bond3 …

Adrenoceptors in GtoPdb v. 2023.1

JG Baker, P Balaji, RA Bond, DB Bylund… - IUPHAR/BPS Guide …, 2023 - journals.ed.ac.uk
Adrenoceptors in GtoPdb v.2023.1 Page 1 IUPHAR/BPS Guide to Pharmacology CITE https://doi.org/10.2218/gtopdb/F4/2023.1
Adrenoceptors in GtoPdb v.2023.1 Jillian G. Baker1, Poornima Balaji2, Richard A. Bond3 …

Adrenoceptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

K Altosaar, P Balaji, RA Bond, DB Bylund… - IUPHAR/BPS Guide …, 2019 - journals.ed.ac.uk
Adrenoceptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database Page 1
IUPHAR/BPS Guide to Pharmacology CITE https://doi.org/10.2218/gtopdb/F4/2019.4 …

[HTML][HTML] Adrenoceptors—New roles for old players

MC Michel, RA Bond, RJ Summers - British Journal of …, 2019 - ncbi.nlm.nih.gov
Adrenoceptors have played a crucial role in the history of pharmacology. They were
essential parts of the work that led to the Nobel Prize in Physiology or Medicine to Sir James …

Subclassification and nomenclature of α-and β-adrenoceptors

JP Hieble - Current topics in medicinal chemistry, 2007 - ingentaconnect.com
The subclassification of α-and β-adrenoceptors has resulted in many opportunities for drug
discovery. Important adrenoceptor targets include β2-agonists as bronchodilators, β1 or …

a-Adrenoceptor Agonists and Antagonists

JP Hieble, RR Ruffolo Jr - Receptor-based drug design, 1998 - taylorfrancis.com
Compounds interacting with the a-adrenoceptors, such as phenethylamines, imidazolines,
and ergot alkaloids, have been used as therapeutic agents for decades. However, many of …

Cardiac β3‐adrenoceptors—A role in human pathophysiology?

E Arioglu‐Inan, G Kayki‐Mutlu… - British Journal of …, 2019 - Wiley Online Library
As β3‐adrenoceptors were first demonstrated to be expressed in adipose tissue they have
received much attention for their metabolic effects in obesity and diabetes. After the …

Recent advances in the identification of a 1-and a 2-adrenoceptor subtypes: therapeutic implications

JP Hieble, RR Ruffolo - Expert Opinion on Investigational Drugs, 1997 - Taylor & Francis
The cloning of multiple subtypes of both a1-and a2-adrenoceptors has renewed interest in
the therapeutic application of agents interacting with these receptors. Effort has primarily …

Why are there so many adrenoceptor subtypes?

G Mllligan, P Svoboda, CM Brown - Biochemical pharmacology, 1994 - Elsevier
* Molecular Pharmacology Group, Departments of Biochemistry and Pharmacology,
University of Glasgow, Glasgow G12 SQQ, Scotland, UK; $ Institute of Physiology, Czech …

Challenges in β3-adrenoceptor agonist drug development

JRS Arch - Therapeutic advances in endocrinology and …, 2011 - journals.sagepub.com
Historical setting In the latter part of the 1970s and the early 1980s three pharmaceutical
companies were attempting to design drugs that would retain the thermogenic and …